Opinion
Plаintiff Ashleigh Brenton filed this action against defendant Metabolife International, Inc. (Mil) alleging that Brenton used Metabolife 356 (the Product), a product manufactured and marketed by Mil, in accordance with the instructions provided by MU, and that she suffered a psychotic *683 breakdown as the result of her use of the Product. Mil appeals the order denying its motion to strike Brenton’s complaint under the anti-SLAPP statute (Code Civ. Proc., § 425.16). 1
I
FACTUAL AND PROCEDURAL BACKGROUND
A. The Complaint
Brenton’s complaint alleged she consumed the Product in accordance with the use instructions fоr a few months before she suffered a psychotic breakdown in June 2000, and that her injuries were caused by the effects of ingredients (including ephedrine) contained in the Product. Brenton pleaded causes of action for product liability, negligence, breach of express and implied warranty and fraud, and sought compensatory and punitive damages. She also alleged that Mil’s false advertising for and misbranding of the Product violated Business and Professions Code sections 17200 and 17500 and sought the remedies provided by those statutes. 2
B. The Anti-SLAPP Motion
Mil moved to strike the complaint under the anti-SLAPP statute. Mil argued Brenton’s complaint targeted Mil’s commercial speech, which can qualify for First Amendment protection (see generally
Va. Pharmacy Bd. v. Va. Consumer Council
(1976)
Brenton opposed the motion to strike, arguing that Mil could not meet the threshold burden to show her claims were within the ambit of the anti-SLAPP statute because her claims were not based on conduct protected by the First Amendment. Brenton also asserted that, even if the court deemed some or all of her claims to be within the ambit of the аnti-SLAPP statute, she could *684 show a reasonable probability of success on the merits. 3 The trial court denied Mil’s motion, and we affirm. 4
II
THE ANTI-SLAPP STATUTE
The anti-SLAPP statute was enacted in 1992 for the purpose of providing an efficient procedural mechanism to obtain an early and inexpensive dismissal of nonmeritorious claims “arising from any act” of a defendant “in furtherance of the person’s right of petition or free speech under the United States or California Constitution in connection with a public issue . . . .” (§ 425.16, subd. (b)(1).) To achieve this objective, the Legislature authorized the filing by a defendant of a special motion to strike those сlaims within 60 days after service of the complaint. (§ 425.16, subds. (b)(1), (f).) An anti-SLAPP motion “requires the court to engage in a two-step process. First, the court decides whether the defendant has made a threshold showing that the challenged cause of action is one arising from protected activity .... If the court finds that such a showing has been made, it then determines whether the plaintiff has demonstrated a probability of prevailing on the claim.”
(Equilon Enterprises v. Consumer Cause, Inc.
(2002)
*685 m
ANALYSIS OF BRENTON’S INDIVIDUAL CLAIMS
A. Ambit of Section 425.16
The anti-SLAPP statute applies only to a “cause of action . . . arising from” acts in furtherance of the defendant’s constitutional right of petition or free speech in connection with a public issue (§ 425.16, subd. (b)(1)), and it is the defendant’s burden in an anti-SLAPP motion to initially show the suit is within the class of suits subject to a motion to strike under section 425.16.
(Fox Searchlight Pictures, Inc. v. Paladino
(2001)
The courts have struggled to refine the boundaries of a cause of action that arises from protected activity. In
City of Cotati v. Cashman
(2002)
B. Brenton’s Individual Claims
The specific issue presented here is a recurring one: 5 whether a claim for physical injury against a manufacturer allegedly caused by use of its product, *686 asserting theories of liability sounding in tort, contract and strict liability, is within the ambit of the anti-SLAPP statute merely because the manufacturer also engaged in commercial speech to market that product. Although section 425.16, subdivision (e) specifies four categories of conduct that qualify for anti-SLAPP protection, Mil’s argument relies on only two of those categoriеs: “any written or oral statement or writing made in a place open to the public or a public forum in connection with an issue of public interest” (subd. (e)(3)) and “any other conduct in furtherance of the exercise of . . . the constitutional right of free speech in connection with a public issue or an issue of public interest” (subd. (e)(4)). Mil asserts its labeling of and advertising for the Product constitute written statements made in a place open to the public in connection with an issue of public interest within the meaning оf subdivision (e)(3), and there is widespread public interest in dietary supplements generally and in the Product in particular. Mil also asserts that its labeling of and advertising for the Product are within the meaning of subdivision (e)(4) because labels and advertisements are commercial speech entitled to First Amendment protection and concern dietary supplements, an issue of public interest.
In
Martinez
v.
Metabolife Internat., Inc.
(2003)
As in Martinez, the core of the wrongful injury-producing conduct alleged here is that Mil manufactured and sold a defective product that caused *687 Brenton’s physical injuries, and the theories pleaded here as to Brenton’s individual claims mirror those considered in Martinez. Other than its disagreement with the decision in Martinez, Mil articulates no principled reason that Martinez should not control our decision on the applicability of the anti-SLAPP statute to Brenton’s individual claims. We adhere to Martinez and conclude Brenton’s individual claims are not based on, and do not arise from, protected activity as defined by section 425.16, subdivision (e). Accordingly, the burden never shifted to Brenton to demonstrate a probability she would prevail on her individual claims, and the trial court correctly denied Mil’s anti-SLAPP motion as to Benton’s individual claims.
IV
ANALYSIS OF BRENTON’S UNFAIR PRACTICES CLAIM
Brenton’s unfair practices claim stands on a significantly different footing from her individual claims. The gravamen of the wrongful, injury-producing conduct by Mil on which her unfair practices claim is based is Mil’s commercial speech; allegedly Mil’s false advertising for and misbranding of the Product. However, assuming a clаim alleging unfair business practices based on advertising and labeling would previously have qualified for section 425.16’s procedural protections (compare
DuPont Merck Pharmaceutical Co.
v.
Superior Court
(2000)
A. Section 425.17
The Legislature, based on its finding that there had been a “disturbing abuse of Section 425.16” (§ 425.17, subd. (a)), enacted section 425.17 to limit the application of section 425.16. Section 425.17, effective January 1, 2004, provides in part:
“(c) Section 425.16 does not apply to any cause of action brought against a person primarily engaged in the business of selling or leasing goods or services, including, but not limited to, insurance, securities, or financial instruments, arising from any statement or conduct by that person if both of the following conditions exist:
“(1) The statement or conduct consists of representations of fact about that person’s or a business competitor’s business operations, goods, or services, *688 that is made for the purpose of obtaining approval for, promoting, or securing sales or leases of, or commercial transactions in, the person’s goods or services, or the statement or conduct was made in the course of delivering the person’s goods or services.
“(2) The intended audience is an actual or potential buyer or customer, or a person likely to repeat the statement to, or otherwise influence, an actual or potential buyer or customer . . . .”
Section 425.17, subdivisiоn (c) appears to remove Brenton’s unfair practices claim (as well as her individual claims) from the types of claims against which an anti-SLAPP motion can be filed. Mil does not contest that application of subdivision (c) here would be fatal to its present anti-SLAPP motion. Mil instead argues that (1) application of section 425.17 to this action would be an improper retroactive application of the statute, and (2) in any event, section 425.17 cannot be applicable because it is unconstitutional.
B. The Retrospectivity Claim
Absent an express declaration of retrospectivity or other clear indication that the Legislature intended retrospective application, a new statute is presumed to operate prospectively.
(Tapia v. Superior Court
(1991)
However, “[t]here remains the question of what the terms ‘prospective’ and ‘retrospective’ mean.”
(Tapia
v.
Superior Court, supra,
*689
In contrast to changed substantive statutes, applying changed procedural statutes to the conduct of еxisting litigation, even though the litigation involves an underlying dispute that arose from conduct occurring before the effective date of the new statute, involves no improper retrospective application because the statute addresses conduct in the future. “Such a statute ‘ “is not made retroactive merely because, it draws upon facts existing prior to its enactment .... [Instead,] [t]he effect of such statutes is actually prospective in nature since they relate to the procеdure to be followed in the future. [”] ’ [Citation.] For this reason, we have said that ‘it is a misnomer to designate [such statutes] as having retrospective effect.’ [Citation.]”
(Tapia v. Superior Court, supra,
It is the effect of the law, not its form or label, that is important for purposes of this analysis.
(Tapia v. Superior Court, supra,
Section 425.17 is properly characterized as a procedural statute applicable to pending actions. In
Robertson
v.
Rodriguez
(1995)
The rationale of
Governing Board v. Mann, supra,
Paraphrasing Mann, MII’s authority to seek dismissal under section 425.16 “rests solely on statutory grounds, and thus under the settled common law rule the repeal of the . . . statutory authority [by newly enacted section 425.17] necessarily defeats” the effort to invoke the statute to justify dismissаl, “even if a [trial court] judgment has been entered and the cause is pending on appeal.”
MII argues that applying section 425.17 in this case would change the legal consequences of past conduct because its authorized past conduct— filing a section 425.16 motion at trial—would become unauthorized conduct. 6 However, the fact that a party acted in an authorized manner at the time he or she invoked the former version of a procedural or remedial statute at trial is no impediment to the appellate court applying the current version of that procedural or remedial statute when evaluating the appeal from the trial court’s ruling. (Governing Board v. Mann, supra, 18 Cal.3d at pp. 829-831; Chapman v. Farr, supra, 132 Cal.App.3d at pp. 1024-1025 [collecting cases].)
Accordingly, the provisions of section 425.17, subdivision (c) properly apply to the present action and provide an independent basis for affirming the trial court’s order denying MII’s anti-SLAPP motion as to Brenton’s individual claims and unfair practices claim.
(Tippett v. Terich, supra,
C. The Constitutional Issue
Mil asserts section 425.17, subdivision (c) cannot be applied to this or any other action because it is a regulation of or restriction on commercial speech
*692
that must satisfy the strict scrutiny standard of
Central Hudson Gas & Elec.
v.
Public Serv. Comm’n
(1980)
MII’s attempt to subject section 425.17, subdivision (c) to the
Central Hudson Gas
analysis is unpersuasive because that statute does not purport to regulate, restrict, condition or penalize Mil’s ability as a speaker to engage freely in commercial speech; it merely regulates or restricts Mil’s ability as a litigant to seek dismissal of certain lawsuits at a particular stage of the litigаtion. Mil cites no authority holding a speaker has a First Amendment right to specialized procedural remedies against a private lawsuit seeking to impose liability for unprotected commercial speech,
7
and we are unaware of any case law holding there is a constitutional imperative that a legislature must make procedural screening devices available to preempt those private lawsuits. (Cf.
Watson v. Fair Political Practices Com.
(1990)
*693 DISPOSITION
The judgment is affirmed. Brenton shall recover her costs on appeal.
Huffman, Acting P. J., and Nares, J., concurred.
Notes
All statutory references are to the Code of Civil Procedure unless othеrwise specified.
For ease of reference, Brenton’s causes of action for product liability, negligence, breach of express and implied warranty and fraud are denominated as her “individual claims,” and her claim under Business and Professions Code sections 17200 and 17500 is denominated as her “unfair practices” claim.
Brenton’s
probability of success
showing relied on numerous documents, including articles from medical publications drawing a connection between consumption of products containing ephedrine and adverse physical reactions, including psychotic episodes; medical texts showing risks to persons from ephedrine consumption; and deposition transcripts from doctors who testified in other cases to the linkage between the Product and health problems suffered by a consumer of the Product. The trial court sustained evidentiary objections to all of Brenton’s evidence except one scientific study, and concluded the one remaining study was a sufficient evidentiary showing to support a finding of probable success on Brenton’s claim for fraud and her Business and Professions Code sections 17200 and 17500 claim. MB’s secondary argument—that Brenton’s showing was insufficient to satisfy her burden of showing a reasonable probability of success on the merits—is moot because her individual claims do not arise out of protected conduct
(Paul
v.
Friedman
(2002)
The trial court denied the motion, reasoning that: (1) MB did not demonstrate the produсt liability, negligence, fraud, and breach of implied warranty claims arose out of conduct protected by the anti-SLAPP statute; and (2) although the express warranty claim and the unfair practices claim did arise out of protected conduct, Brenton had shown a reasonable probability of prevailing on the merits of those claims. Because we agree with the trial court’s order, although not necessarily all of the rationales for the order, we affirm.
(Tippett
v.
Terich
(1995)
The Legislature’s adoption of section 425.17, subdivision (c) has effectively mooted this recurring problem insofar as future cases are governed by subdivision (c), and we also conclude below (see pt. IV.B., post) that section 425.17, subdivision (c) provides an independent basis for affirming the trial court’s order as to Brenton’s individual claims. However, we *686 separately evaluate her individual claims without regard to section 425.17, subdivision (c) because, even if that provision cannot be applied to her claims because of retroactivity concerns or alleged cоnstitutional infirmities in that statute, the trial court’s order as to Brenton’s individual claims was nevertheless proper without reference to section 425.17.
Mil also argues applying section 425.17 would retroactively deprive Mil of its right to be free of meritless lawsuits. However, applying section 425.17 here does not eliminate that purported
right,
but only removes one procedural mechanism for enforcing that right and requires Mil to enforce the right to be free of meritless lawsuits by other procedures or remedies. (Cf.
Jarrow Formulas, Inc. v. La Marche
(2003)
The cаses that have considered analogous issues have held the First Amendment does not impede the state from awarding monetary or injunctive relief for claims asserting the defendant engaged in unprotected commercial speech. For example, in
People
v.
Superior Court (Olson)
(1979)
